Blood Transfusion Diagnostics Companies

Latest Blood Transfusion Diagnostics Companies Updates:

Roche Diagnostics: Launched the cobas® m511 analyzer in October 2023, offering a high-throughput platform for automated ABO and Rh blood typing with advanced features for accuracy and efficiency.

Grifols, S.A.: Received FDA approval for their Procleix® Panther Fusion™ system in July 2023, enabling simultaneous testing for multiple infectious diseases in donated blood with rapid turnaround times.

Immucor, Inc.: Partnered with Google Cloud in September 2023 to develop AI-powered tools for analyzing blood donor data and predicting potential transfusion risks.

Bio-Rad Laboratories, Inc.: Introduced the Micro Typing System™ with MicroVue™ ABO/Rh cards in December 2023, providing a reliable and portable option for blood typing in resource-limited settings.

Diagnoptics for the Developing World: Received funding from the Bill & Melinda Gates Foundation in January 2024 to develop and distribute affordable, rapid blood typing tests for low- and middle-income countries.

List of Blood Transfusion Diagnostics Key companies in the market:

• Roche Diagnostics (Switzerland)


• bioMérieux (France)


• Bio-Rad Laboratories, Inc. (U.S.)


• Immucor (U.S)


• Siemens Healthineers (Germany)


• Ortho Clinical Diagnostics, Inc. (U.S.)


• Becton, Dickinson and Company (U.S.)


• Novartis AG (Switzerland)


• Beckman Coulter, Inc. (U.S.)